SMA manifests across a range of clinical subtypes defined historically by maximal motor function, and severity largely correlates negatively with the number of copies of SMN2, a partially functional paralog of SMN1 [2]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.